MYX mayne pharma group limited

In a forward looking market one would think the E4 FDA approval...

  1. 369 Posts.
    lightbulb Created with Sketch. 205
    In a forward looking market one would think the E4 FDA approval would have seen us hold at least around the
    50cent mark on projected earnings,coupled with the fact that we have 85% of the OC market.
    But unfortunately, investors are weary of this abysmal management team and got out the minute they could.
    Shorts actually increased the minute the FDA approval was out as they know it'll be a very short lived spike as there will be no information
    coming forward ,which will allow the price to drift and be manipulated.
    I emailed Pendlebury questioning what is being done to put a floor under the SP instead of this constant drifting back to ground zero after each announcement.
    Im yet to receive a response.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.07
Change
0.050(1.00%)
Mkt cap ! $411.9M
Open High Low Value Volume
$5.00 $5.14 $4.94 $712.4K 141.2K

Buyers (Bids)

No. Vol. Price($)
1 1059 $5.07
 

Sellers (Offers)

Price($) Vol. No.
$5.13 1000 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.